Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Ask the Pharmacist Question: I just listened to the multi dis perspective BTK inhibitors webinar. I thought I heard calcium channel blockers are contraindicated with ibrutinib. Wondering if this is true? Whether 2.5 mg of norvasc would be contraindicated with
Ask the Pharmacist Question: I am presently using imbruvica for CLL and have had great success in my blood counts. I am experiencing very minor side-effects that have been very tolerable. However, I seem to have heightened anxiety and possibly some depression.
Ask the Doctor Question: In the early Stages of the COVID epidemic, my doctor suggested I supplement my diet with Vitamin C, along with masking, social distancing, etc. Recently, in some of the CLL groups, I have been seeing that
Ask the Doctor Question: I have been receiving IVIG replacement (usually four times a year) when my levels have dropped below 400 for over a decade. Though, depending on the medical facility or the physician, this seems to be all
Ask the Doctor Question: My mother’s CLL has now relapsed after receiving chemo in 2019. Is Imbruvica the only solution to this or there is any other option? Answer: There are many treatment options now for CLL and in fact, too
Ask the Doctor Question: I have to start my first therapy soon and living in Germany. First diagnosis in 2015 and until now, watch and wait. ighv mutated, trisomie12, birc3 mutation. WBC 60,000, platelets 100,000, Hämoglobin 10,5. Does acalabrutinib work
Ask the Pharmacist Question: What steps can I take to improve absorption of acalabrutinib. I had a total gastrectomy in 1974 and a Roux en Y in 2005, so my compromised stomach is not absorbing that 100mg oral medication I
Ask the Doctor Question: I am 66 years old and diagnosed with CLL three-years ago. My WBC auto was 71.3 three-months ago, but now jumped to 178.1. My doctor is telling me it’s time to start therapy and has recommended
Ask the Doctor Question: My husband is a CLL patient and on 5/12/2021 he started treatment with Ibrutinib. After two-months, today we were informed of his analytical results: WBC decreased from 191*10^e/ul to 181*10^3/ul. Lymohocites decreased from 153*10^3/ul to 152*10^3/ul.
One click to our most popular content.
